SCHEMBL7980989

SCHEMBL7980989

CC(C)OCCn1c(NC2CCNCC2)nc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 9/20 0.58
NR4A2 P43354 1/20 0.58
SSTR5 P35346 4/20 0.42
IRAK4 Q9NWZ3 1/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
MLNR O43193 1/20 0.42
CACNA1F O60840 1/20 0.42
EED O75530 1/20 0.42
USP2 O75604 1/20 0.42
ABCB11 O95342 1/20 0.42
EGFR P00533 1/20 0.42
LMNA P02545 1/20 0.42
HLA-A P04439 1/20 0.42
ERBB2 P04626 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
LCK P06239 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991613 0.86 KCNH2 (0.59) KCNH2NR4A2MEN1CHRM1HRH1
SCHEMBL9536919 0.83 KCNH2 (0.58) KCNH2NR4A2SSTR5SMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL7985497 0.82 KCNH2 (0.60) KCNH2NR4A2SSTR5GAAMAPT
SCHEMBL7985049 0.82 KCNH2 (0.65) KCNH2NR4A2SSTR5IRAK4MKNK1
SCHEMBL9534952 0.81 KCNH2 (0.61) KCNH2NR4A2SSTR5MAPTUSP2
SCHEMBL7492402 0.81 KCNH2 (0.59) KCNH2NR4A2SSTR5GAAMAPT
SCHEMBL7988149 0.79 ALDH1A1 (0.48) KCNH2GAAMAPTSMN1; SMN2LMNA
SCHEMBL7981124 0.79 KCNH2 (0.61) KCNH2NR4A2SSTR5IRAK4MAPT
SCHEMBL6992893 0.78 KCNH2 (0.59) KCNH2NR4A2IRAK4MAPTSMN1; SMN2
SCHEMBL5537223 0.78 KCNH2 (0.58) KCNH2NR4A2SSTR5IRAK4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211199-B1 HISTAMINE AND TACHYKININ RECEPTOR ANTAGONISTS; ANTIASTHMATICS, ANTIEMETICS; RESPIRATORY SYSTEM DISORDERS, INFLAMMATORY BOWEL DISEASE, CONJUNCTIVITIS AVENTIS PHARMACEUTICALS INC. 2001-04-03 US disclosed